Clinicopathologic study and outcome analysis of thyroid lymphomas: Experience from a tertiary cancer center (Record no. 33168)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01984pab a2200385 454500 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 150901b2013 xxu||||| |||| 00| 0 eng d |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | Tata Memorial Hospital |
041 ## - LANGUAGE CODE | |
Language code of text/sound track or separate title | English |
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER | |
Classification number | |
Item number | |
100 ## - MAIN ENTRY--PERSONAL NAME | |
Personal name | Katna R |
245 ## - TITLE STATEMENT | |
Title | Clinicopathologic study and outcome analysis of thyroid lymphomas: Experience from a tertiary cancer center |
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
Date of publication, distribution, etc. | 2013 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 165-171 |
490 ## - SERIES STATEMENT | |
Series statement | |
Volume/sequential designation | Vol 35 Issues 2 |
520 ## - SUMMARY, ETC. | |
Summary, etc. | BACKGROUND: The aim of this study was to review clinicopathologic presentations of patients diagnosed with thyroid lymphomas at a tertiary cancer center. Thyroid lymphomas represent less than 2% of all lymphomas. METHODS: The lymphoma clinic database was retrospectively reviewed to collect information on patients diagnosed with thyroid lymphomas. Tissue microarrays were constructed in 37 patients for evaluation of germinal center (CD10/bcl-6) and activated B-cell immunophenotype markers (FoxP1, Mum1). RESULTS: During 2000 to 2010, 64 of 5668 patients registered at our lymphoma clinic were diagnosed with thyroid lymphoma (1.7%). Complete response (CR) to treatment was seen in 80.7%. The germinal center immunophenotype and activated B-cell immune phenotype did not influence the prognosis. FoxP1, however, was associated with poor treatment response and decreased survival. CONCLUSIONS: Advanced International Prognostic Index (IPI) score and combined-modality treatment emerged as significant prognostic |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | International Prognostic Index,,, |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Thyroid lymphomas |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Clinicopathologic study |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | |
700 ## - ADDED ENTRY--PERSONAL NAME | |
Personal name | Nair R |
700 ## - ADDED ENTRY--PERSONAL NAME | |
Personal name | DCruz AK |
700 ## - ADDED ENTRY--PERSONAL NAME | |
Personal name | Prabhash K |
700 ## - ADDED ENTRY--PERSONAL NAME | |
Personal name | Laskar S |
700 ## - ADDED ENTRY--PERSONAL NAME | |
Personal name | Menon H |
700 ## - ADDED ENTRY--PERSONAL NAME | |
Personal name | Sengar M |
700 ## - ADDED ENTRY--PERSONAL NAME | |
Personal name | Shet T |
700 ## - ADDED ENTRY--PERSONAL NAME | |
Personal name | |
773 ## - HOST ITEM ENTRY | |
Host Biblionumber | 78186 |
Main entry heading | Head and Neck |
906 ## - LOCAL DATA ELEMENT F, LDF (RLIN) | |
a | Feb |
907 ## - LOCAL DATA ELEMENT G, LDG (RLIN) | |
a | Journal Article |
907 ## - LOCAL DATA ELEMENT G, LDG (RLIN) | |
a | 22368156 |
907 ## - LOCAL DATA ELEMENT G, LDG (RLIN) | |
a | Surgical Oncology-Head and Neck |
907 ## - LOCAL DATA ELEMENT G, LDG (RLIN) | |
a | TMH |
907 ## - LOCAL DATA ELEMENT G, LDG (RLIN) | |
a | TMC |
Withdrawn status | Lost status | Damaged status | Not for loan | Permanent Location | Current Location | Date acquired | Cost, normal purchase price | Full call number | Barcode | Date last seen | Price effective from | Koha item type |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Tata Memorial Hospital | Tata Memorial Hospital | 2012-04-10 | 0.00 | AR12370 | 2015-09-02 | 2015-09-02 | Articles |